Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | F9 | P00740 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23593068 | 0.83 | KDM4E (0.42) | GPR3ALDH1A1PGR | |
| SCHEMBL17012824 | 0.82 | IDO1 (0.36) | GPR3L3MBTL1CNR1CNR2ALDH1A1 | |
| SCHEMBL23593056 | 0.82 | KDM4E (0.41) | GPR3ALDH1A1PGR | |
| SCHEMBL17533936 | 0.81 | GPR3 (0.40) | GPR3L3MBTL1HSP90AA1PARP14F9 | |
| SCHEMBL23593067 | 0.79 | GPR3 (0.35) | GPR3ALDH1A1 | |
| SCHEMBL23593061 | 0.79 | SLC9A1 (0.39) | GPR3L3MBTL1HSP90AA1PARP14ALDH1A1 | |
| SCHEMBL23592348 | 0.79 | PDK2 (0.35) | F9 | |
| SCHEMBL23593111 | 0.79 | ALK (0.32) | F9 | |
| SCHEMBL24036872 | 0.78 | IDO1 (0.41) | L3MBTL1ALDH1A1MAPK1 | |
| SCHEMBL17367224 | 0.78 | PDE10A (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10749118-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-08-18 | — | — | US | disclosed |
| US-10370473-B2 | Compound, curable composition, cured product, optical member, and lens | FUJIFILM CORPORATION (JP) | 2019-08-06 | — | — | US | disclosed |
| US-20150380663-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-31 | — | — | US | disclosed |
| US-20150380663-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10370473-B2 | Compound, curable composition, cured product, optical member, and lens | CRYZ, CRYAA, UACA | GPR3 3594/4885L3MBTL1 1918/4885HSP90AA1 3837/4885 |
| US-20150380663-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CYP1A1, CRY1, CYP1B1 | GPR3 2488/4885L3MBTL1 717/4885HSP90AA1 4457/4885 |
| US-10749118-B2 | Heterocyclic compound and organic light-emitting device including the same | CYP1A1, CRY1, CYP1B1 | GPR3 2488/4885L3MBTL1 717/4885HSP90AA1 4457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.